Alpha Tau Medical (DRTS) Cash from Financing Activities (2021 - 2022)
Alpha Tau Medical (DRTS) posted quarterly Cash from Financing Activities of $14.8 million for Q2 2022, down 81.93% on a QoQ basis from $82.0 million in Q1 2022.
Alpha Tau Medical (DRTS) Cash from Financing Activities (2021 - 2022) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Cash from Financing Activities for 2 consecutive years, with $14.8 million the latest figure, recorded in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Alpha Tau Medical | 1.19 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 14.82 Mn |
| Jun 30, 2022 | 14.82 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Mar 31, 2022 | 81.99 Mn |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |